NDC 80610-130

roflumilast

Roflumilast

roflumilast is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Arcutis Biotherapeutics, Inc.. The primary component is Roflumilast.

Product ID80610-130_12ae3725-8b80-435d-b049-78d2b6f815d3
NDC80610-130
Product TypeHuman Prescription Drug
Proprietary Nameroflumilast
Generic NameRoflumilast
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2022-07-29
Marketing CategoryNDA /
Application NumberNDA215985
Labeler NameArcutis Biotherapeutics, Inc.
Substance NameROFLUMILAST
Active Ingredient Strength3 mg/g
Pharm ClassesPhosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 80610-130-60

1 TUBE in 1 CARTON (80610-130-60) > 60 g in 1 TUBE
Marketing Start Date2022-07-29
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "roflumilast" or generic name "Roflumilast"

NDCBrand NameGeneric Name
0378-1905RoflumilastRoflumilast
13668-476RoflumilastRoflumilast
31722-623RoflumilastRoflumilast
42571-259ROFLUMILASTRoflumilast
43547-005ROFLUMILASTroflumilast
64380-786roflumilastROFLUMILAST
68382-969RoflumilastRoflumilast
70771-1674RoflumilastRoflumilast
72205-200RoflumilastRoflumilast
72205-201RoflumilastRoflumilast
80610-130roflumilastroflumilast
0310-0088Daliresproflumilast
0310-0095Daliresproflumilast
55154-4625Daliresproflumilast

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.